chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Runny nose after 2nd shot; Radiating pain after 2nd shot; Fever 102 F after 2nd shot; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Runny nose after 2nd shot), PAIN (Radiating pain after 2nd shot) and PYREXIA (Fever 102 F after 2nd shot) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     The patient's past medical history included Cardiac arrhythmia (NOS). Concurrent medical conditions included Immunocompromised and Asthma. Concomitant products included SALBUTAMOL SULFATE (PROAIR HFA) and TIOTROPIUM BROMIDE MONOHYDRATE (SPIRIVA) for Asthma.    On 07-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced RHINORRHOEA (Runny nose after 2nd shot), PAIN (Radiating pain after 2nd shot) and PYREXIA (Fever 102 F after 2nd shot). The patient was treated with PARACETAMOL (TYLENOL) on 07-Apr-2021 for Pain, at an unspecified dose and frequency. On 08-Apr-2021, RHINORRHOEA (Runny nose after 2nd shot) and PYREXIA (Fever 102 F after 2nd shot) had resolved. On 09-Apr-2021, PAIN (Radiating pain after 2nd shot) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Apr-2021, Body temperature: 102 (High) high. On an unknown date, Heart rate: abnormal (abnormal) irregular.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had radiating pain for 2.5 days   This case was linked to MOD-2021-315707, MOD-2021-315546 (Patient Link).
Very limited information provided to Health Center via Hospital.  Patient was admitted to hospital on 12/28/21 for vaccination break-thru COVID 19 with fatigue, cough, SOB, and difficulty breathing.  Diagnosis included COVID-19 pneumonia, acute respiratory failure.  Patient had provided dates that Pfizer vaccine was given (1/11/21, 2/1/21, 10/25/21), but the information was not in the system.  No Lot number information was provided.  Date of discharge was not provided.  Death certificate was obtained and noted that case had died on 2/1/22 at a long term care facility with cause of death being listed as sudden respiratory arrest, COVID-19, hypertension, and diabetes.
I have experienced something unusual, a sharp pain in my left knee right near the knee cap; Left knee cap; This is a spontaneous report from a contactable consumer. This consumer (patient) reported that. Unspecified age and sex patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number and expiration date not reported), via an unspecified route of administration on an unspecified anatomical location on 14Jan2021 as a dose 1, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Patient experienced something unusual, a sharp pain in my left knee right near the kneecap, left kneecap on unspecified date. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received from a consumer concerning her 7-year-old son who on 29-JAN-1999 and 29-SEP-1999 was vaccinated with his first, second and third doses of hepatitis B virus vaccine rHBsAg (yeast) (manufacturer unknown).  Secondary suspect therapy included the first, second, third and fourth doses of Hib conj vaccine (manufacturer unspecified) given on 03-MAR-1999, 07-may-1999, 01-JUL-1999 and 19-APR-1999.  In August 2006, the patient was diagnosed with autism and Tourette's syndrome.  Another physician diagnosed her son with anxiety disorder and OCD obsessive compulsive disorder.  One of the physicians believed that the possible cause could be the thimerosal in the vaccines he received as an infant.  The mother reported that they cut out all dairy products, wheat and preservatives out of her son's diet with some noted improvement noted in his behavior.  He has difficulty making decisions and sleeping at night.  The following laboratory/diagnostic tests have been done,mercury level=0.001 ug/g, zinc 8.9 and magnesium level=41.  No further information was available at the time of this report.  The patient's vaccination history included: a dose of IVP, rotavirus vaccine (unspecified) given on 07-MAY-1999 and 01-JUL-1999, diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid given on 03-MAR-1999, 07-MAY-1999, 01-JUL-1999, 19-APR-2000 and 02-JAN-2003.  The patient's mother indicated that she wanted her pediatric office to "do a lot check".  Upon internal review, autism was determined to be an other important medical event.  Additional information has been requested. (OMIC)
This spontaneous report received from a patient, concerned a patient of unspecified age and gender. Medical history, weight, height, concomitant medications and concurrent conditions not reported. The patient received COVID-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch/lot number: not reported) dose, start therapy date: not reported, for immunization. Unable to perform follow-up to request batch/lot numbers. On an unspecified date, patient experienced side effects with the COVID-19 vaccine. The action taken with COVID-19 vaccine ad26.cov2.s: not applicable. The outcome: not reported.
Cold (cannot get warm) Nausea with throwing up every 5 minutes Severe headache Severe dizziness
Four days post vax, this pt developed greater than 100 rash with low-grade fever. He had no recent exposure to varicella. At the time of this report his condition had worsened.
Dermatographic urticaria. Random outbursts of itchy red lines/patches all over body. Skin easily swelling up with any scratching. Zyrtec was taken to treat itchiness and swelling of the skin but only relieves the symptoms for about 12hrs even though medication is for 24hrs. A Zyrtec has to be taken daily in order to reduce itchiness.
Administer Expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) in a 74-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine). On 29-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. No treatment was given to the patient.  The pharmacist reported about the administration of expired Moderna vaccine that was given as booster shot to patient. The vaccines was stored in freezer, which was taken out one to two vials and place in fridge each day as needed. The lot number of the vaccine was 031B21A(22 Sep 2021).
The one that got shingles, got shingles vaccine/suspected vaccination failure; shingles; Inappropriate age at vaccine administration; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a child patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included chickenpox (Family History) (6 of children including patient in the family had the chicken pox).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and inappropriate age at vaccine administration. On an unknown date, the outcome of the vaccination failure, shingles and inappropriate age at vaccine administration were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient's parent. The age at vaccination was not reported. The reporter stated that all 6 of children in family had the chicken pox and the only one that got shingles was the one that got the shingles vaccine. The reporter would pass on it. This case was considered as suspected vaccination failure since details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation was not provided. Note: As per narrative the age group was captured as child and event inappropriate age at vaccine administration was captured as event conservatively.
Appeared to be syringe malfunction, may have cracked when needle was applied to prefilled syringe. When attempted to give, vaccine came out around needle hub and was not injected. No adverse effect and repeat vaccination was given after discussion with pharmacy.
Started coughing a weird cough.  Then chest became very heavy and struggled to get a full breath.
The morning after flu vaccination, he had fever, headache, and tiredness. He developed a dry cough by the 2nd day. All these symptoms continued and worsened until he was bedridden on the 4th day. On the 5th day, he went to urgent care because symptoms worst of any day and fever 104 degrees. His physician ordered labs and he was admitted to the hospital that evening. He had elevated liver enzymes, low WBC, and low platelets. They ran tests for 2 days with none of them positive.  He was released on the 3rd day with no answers.
Pain and swelling has increased over the last 3 days. Red, swollen and extremely painful
This spontaneous report as received from a registered nurse refers to an unknown number of patients of unknown age and gender. Relevant medical history and concomitant medication was not provided. On 31-OCT-2013 the patients were vaccinated with M-M-R II lot number J002505. Dose, route and frequency were not provided. On 31-OCT-2013, the patients were vaccinated with M-M-R II stored as high as 47F for up to 44 hours. No adverse effects were reported. This case was linked to MARRS case numbers 1311USA008054, 1311USA007704, 1311USA007705, 1311USA007695, 1311USA007696, 1311USA007699, 1311USA007701, 1311USA007702, 1311USA007703, 1311USA007698, 1311USA007697, 1311USA008057, 1311USA008058, 1311USA008059, 1311USA008060, 1311USA008055, 1311USA000906, 1311USA008061, 1311USA008056 (same reporter link). Additional information has been requested.
Sudden onset of 102 fever, with cold hands and feet.  Extreme drowsiness and disorientation. No other symptoms (such as respiratory illness).
Client called office states she has flu like symptoms, fever, N/V and pain. She feels she may have had reaction to pneumonia shot.
PFIZER COVID VACCINE #3 GIVEN 12/29/21, LOT #FJ8757; 1/4/22 pt had a positive COVID test from Urgent Care; 1/9 - 1/19/22 pt had a hospitalization (name of hosp unknown) with COVID pneumonia; 2/7 - 2/26/22 pt brought to hospital again with increasing weakness, falling, and poor oral intake; CXR showed improvements, still with bilateral interstitial and patchy alveolar opacities; AKI;  pt had a seizure in the hospital; found to have HSV-2 meningitis; treated with Acyclovir; seizure medications given for seizures; poor prognosis; transitioned to comfort care; dc'd to Life Care Center on  hospice; pt expired in the Life Care Center
did not feel comfortable; headache in the right side/stood up ok with the headache/headache got worse when the patient laid down; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (did not feel comfortable) and HEADACHE (headache in the right side/stood up ok with the headache/headache got worse when the patient laid down) in a 97-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concomitant products included CARBIDOPA, LEVODOPA (SINEMET) for Parkinson's disease.    On 20-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced FEELING ABNORMAL (did not feel comfortable) and HEADACHE (headache in the right side/stood up ok with the headache/headache got worse when the patient laid down). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (did not feel comfortable) and HEADACHE (headache in the right side/stood up ok with the headache/headache got worse when the patient laid down) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication:Sinemet 25/100mg, 1 tablet 3 times a day
Fatigue; Soreness around the injection site; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 06Apr2021 at 09:30(at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity. The patient did not report any allergies to food, medications or other product. Concomitant medications included ethinylestradiol, etonogestrel (NUVARING) from unknown date, for unknown indication and unknown if it was ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 06Apr2021 at 21:00, the patient experienced soreness around the injection site. On 07Apr2021, the patient experienced fatigue the day following the injection. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events soreness around the injection site and fatigue were recovering at the time of report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Headache slight chills started around 3:00 am .  I woke up and was not able to go back to sleep.  Later in the day, while at work, I became extremely fatigued and my chills were getting worse.  I left work early, came home and checked my temperature.  It has been between 102.5 and 103.7 the entire time I have been home.  Even after taking Tylenol.  My arm is also a little tender at the injection site.    I had COVID prior to this but they say I recovered.    My symptoms started on November 13 and was hospitalized for 3 days starting around day 9 of symptoms.  My current symptoms are pretty much identical to the symptoms I had when I first contracted COVID.
First set of symptoms: within 4-6 hours, I developed flu-like symptoms- headache, body aches, fatigue, malaise.  This lasted almost 48 hours and missed 2 days of work.  Symptoms gradually resolved and I did not seek treatment.  Second set of symptoms: Although being in peri-menopause and not having a period for almost one year, within 4 days of the vaccine I experienced a very severe period.  Heavy cramping, heavy flow, lasting 7 full days.  Also started experiencing hot flashes, headaches, restless sleep. Period came again 3 weeks later, still heavy, cramping, and lasting 7 days.
A Moderna Covid-19 vaccine was administered beyond the use date.  Moving forward we have clearly labeled all vaccine boxes to represent expiration date.  Also, have spoke with staff to pay closer attention to these details so this incident do not occur in the future.
Trigeminal Nerve pain; This is a spontaneous report from a contactable consumer, the patient.  A 47-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 m-RNA VACCINE, formulation: solution for injection, lot number was not reported), via an unspecified route of administration on 23Feb2021 (age at vaccination 47 years) as dose number unknown, single for covid-19 immunisation. The patient had no relevant medical history. The patient was not allergic to medications, food, or other products. The patient did not receive any other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. There were no concomitant medications. On an unknown date in Apr2021, the patient experienced trigeminal nerve pain for 3 weeks. Therapeutic measures were not taken as a result of the event. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event trigeminal nerve pain was unknown.  The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
About 2 hours after receiving vaccine started having headache on Friday, 9/8, was getting kind of lightheaded and started getting a fever and body aches. States her fever got up to 102, took some TYLENOL for that. States on Sunday, had sweats, Temp 101-102, body aches, dizziness and took TYLENOL. Monday feels little lightheaded and dizzy, weak, chills off and on. Has been eating and drinking ok. Has not taken temperature today.
Right eye had pain and blurriness the morning on 12/22. The pain went away within a  few hours but the blurred vision remained. Contacted my primary physician And drops were given to see if they would help. Discontinued at 48 hours because not improving.  Appointment made and seen by Dr 1/8/21 and diagnosed with uveitis. Started on steroid drops which improved the symptoms within several days. Still on the steroid medication due to rebound  after trying to stop the drops.
This case involves a female patient (unknown age) whose arm was not normal after shot and arm could not move (injected limb mobility decreased) after receiving INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT]. The patient's medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (batch number and expiry not reported) via unknown route in the arm Not Otherwise Specified (NOS) for prophylactic vaccination. On an unknown date the patient developed a non-serious "arm was not normal after shot and arm could not move" (injected limb mobility decreased) (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. It was reported "I don't know if this is the right place that I should be, but my arm is like not normal after my shot, and I had to Flu zone and my arm I can't move my arm it's been a month so let me know what's going on I don't know if this is the right place, I'm supposed to be so okay." No laboratory data was reported. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the event was not resolved. There will be no information available on the batch number for this case.
Patient woke up the morning after the vaccine was administered and had a red circle at the injection site. It was hot to the touch and painful when she touched it. After 4 days of no change in symptoms patient went to the urgent care and was given antibiotics. She was told she had cellulitis. After 2 days of antibiotics her arm felt better and was now gone.
neck pain; back pain; green tongue; tongue became swollen; mouth became swollen; This non-serious case was reported by a consumer via call center representative and described the occurrence of swollen tongue in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 25-APR-2023, the patient received the 1st dose of Shingrix (left arm). On 26-APR-2023, 1 days after receiving Shingrix, the patient experienced swollen tongue (Verbatim: tongue became swollen) and swollen mouth (Verbatim: mouth became swollen). On an unknown date, the patient experienced neck pain (Verbatim: neck pain), back pain (Verbatim: back pain) and tongue discoloration green (Verbatim: green tongue). The patient was treated with steroids nos (Steroids) and dramamine (nos) (Dramamine). The outcome of the swollen tongue, swollen mouth, neck pain, back pain and tongue discoloration green were unknown.   It was unknown if the reporter considered the swollen tongue, swollen mouth, neck pain, back pain and tongue discoloration green to be related to Shingrix.  It was unknown if the company considered the swollen tongue, swollen mouth, neck pain, back pain and tongue discoloration green to be related to Shingrix.   Additional Information: GSK Receipt Date: 05-MAY-2023 The reporter was the patient, who received her Shingrix last Tuesday in her left arm.  She stated that the next day, her tongue and mouth became swollen and she had neck and back pain.  Her tongue also turned green.  When she went to her doctor, she received steroids and Dramamine to help with the swelling.  The reporter consented to follow up.
Symptoms of heart attack: Severe chest pain, numbness in left arm, dizzy, pale  Treated at Emergency Dept. at hospital, EKG did not show any abnormal heart activity.  Two tests for heart enzyme were negative. Subsequent stress test showed normal heart activity; although, chest pain during test.
No additional AEs were reported; patient received an expired PROQUAD; This spontaneous report as received from a certified medical assistant refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions, allergies and concomitant therapies was provided.  On 28-JAN-2022, the patient was vaccinated with an expired 1 dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live rHA (recombinant human albumin) (PROQUAD), lot # T019420, expiry date 02-DEC-2021 (exact dose, route and site of administration were not reported) for prophylaxis (expired product administered). No additional adverse events were reported (no adverse event).
She experienced decreased immunity; I too had loss of energy; This is a spontaneous report from a contactable consumer reported for a 63-year-old female patient (reporter's mother) via Medical Information Team. A 63-year-old female patient received bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot Number: Not reported), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced decreased immunity and loss of energy. The clinical outcome of both the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Pt c/o numbness and tingling in left arm.  Went to the ER for observation.
On evening after vaccine administration client noticed red rash on shoulder area above deltoid where vaccine was given. Presented to HD for evaluation on following day. Has large area of red macular papular rash, blandres. Puncture site and around puncture site. No redness or induration. Client reports rash is becoming puritic, but has no SOB, wheezing, etc. Advised to seek care of physician if rash not improved by 06/14/02.
Dr. gave patient two doses of Tdap and Meningococcal vaccine within 5 months of each other.
Received 4th dose Rabies IZ at 9 am 10/18/06 & at 4pm felt unwell "flu-like" and aching all joints and body and developed fever 102F with chills lasting all night. Residual left shoulder joint pain, shoulder weakness. Only had slight localized pain after 2nd immunization injection in L arm on 10/7/06. Felt "much better and much less ache/pain in left shoulder"in AM of 10/25/06.
pt recvd vax; pt reported redness,warm feeling w/ blister like patches to inject site;sxs started 4nov94,site very sore;